Novo Nordisk's CEO took a $1.5 million pay cut in 2024 as the pharma giant's share price tanked and it missed profit and DEI ...
Ozempic has been approved to reduce the risk of worsening kidney disease and cardiovascular death in adults with Type 2 ...
Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...
The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
Medicare is preparing to negotiate prices on GLP-1 drugs such as Ozempic. Novo Nordisk investors could see the news put $14.3 billion in Medicare revenue at risk. Viking Therapeutics stock, in ...
In this article, we are going to take a look at where Novo Nordisk A/S (NYSE ... on AI optimism and President Trump’s new term in office. On Wednesday, January 22, stocks finished higher as ...
Insider Monkey on MSN21d
Is Novo Nordisk (NVO) the Best Stock to Buy and Hold for 2025?In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO ... as technology stocks rallied on AI optimism and President Trump’s new term in office. On Wednesday, January 22, ...
J&J beats quarterly sales and profit estimates on cancer drug sales Novo Holdings ... than those who were given Novo Nordisk's Wegovy in the first large, head-to-head trial of the highly in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback